NICE approves more tolerable treatment for blood cancer
Around 2,200 patients a year with multiple myeloma are to benefit from a new, tolerable treatment on the NHS following approval by NICE.
Latest news headlines
Paramedics with advanced training can reduce the number of patients admitted to hospital unnecessarily, says NICE.
03 July 2017
Bylaws could be introduced as a way to enforce ‘no vehicle idling’ in areas where vulnerable people collect (for example schools, hospitals and care homes).
30 June 2017
NHS patients in England are getting early access to new drugs for lung cancer and sarcoma, after NICE says they should be available on the Cancer Drugs Fund (CDF).
28 June 2017
NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research groups, who are developing transformative products that have the potential to change patients’ lives and/or save the NHS money.
27 June 2017
NICE is calling for people who are eligible for free flu vaccination to be offered it at every opportunity.
26 June 2017
Thousands of patients to benefit from roflumilast, also known as Daxas, to treat chronic obstructive pulmonary disease (COPD) after NICE says it should be more widely available.
22 June 2017